Abstract 4372348: Characterization and Prognostic Implications of Pulmonary Hypertension on Right Heart Catheterization Among Patients with Myeloproliferative Neoplasms

O Orly Leiva (University of Chicago, Chicago, Illinois, United States) S Steven Soo (New York University, New York City, New York, United States) O Olivia Liu (New York University, New York City, New York, United States) J Justin Kahla (University of Chicago, Chicago, Illinois, United States) Y Yasmeen Murtaza (University of Chicago, Chicago, Illinois, United States) V Victor You (Massachusetts General Hospital, Boston, Massachusetts, United States) A Andrew Palmer A Anand Patel M Mark Belkin (UNIVERSITY OF CHICAGO, Chicago, Illinois, United States) S Stanley Swat (University of Chicago, Chicago, Illinois, United States) L Leo Gozdecki (University of Chicago, Chicago, Illinois, United States) M manreet kanwar (University of Chicago, Chicago, Illinois, United States) O Olatoysoi Odenike (University of Chicago, Chicago, Illinois, United States) J Joan How (Brigham and Women's Hospital, Boston, Massachusetts, United States) G Gabriela Hobbs (Massachusetts General Hospital, Boston, Massachusetts, United States)

Abstract

Background: Myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF), are chronic leukemias associated with cardiovascular (CV) disease (CVD), including pulmonary hypertension (PH). Prior studies utilizing echocardiography for identifying PH in MPNs have suggested an association between PH and adverse outcomes. However, right heart catheterization (RHC) is required for diagnosis and hemodynamic profiling of PH. Data on RHC-proven PH in MPNs are sparse. Methods: We conducted a multicenter study of patients with MPN who underwent RHC. PH, defined as mean pulmonary artery pressure (mPAP) > 20 mmHg, was hemodynamically characterized into isolated pre-capillary (pre-cap), isolated post-capillary (post-cap), and combined pre- and post-capillary (Cpc-PH). Outcomes were heart failure hospitalization (HFH) or CV death, and all-cause death. Multivariable Cox proportional hazards regression was performed. To model total number of HFH, multivariable negative binomial regression was performed. Results: 85 patients were included, 70 (82.4%) had PH, 37 (43.5%) were female, and 68 (80.0%) were White. Among PH patients, 30 (42.9%) had pre-cap PH, 12 (17.1%) post-cap PH, and 28 (40.0%) Cpc-PH. Age, gender, time from MPN to RHC, MPN type and driver and non-driver mutations did not differ between patients with or without PH. Patients with PH were more likely to have prior HFH (35.7% vs 0%, p = 0.006). After a median follow-up of 31.4 months, HFH or CV death occurred in 57 (67.1%) patients and death in 49 (57.6%). After adjustment, pre-cap (aHR 2.69, 95% CI 1.00 – 7.27) and post-cap PH were associated with increased risk of HFH or CV death (aHR 4.12, 95% CI 1.26 – 13.50) versus no PH. After multivariable negative binomial regression, any PH (IRR 3.36, 95% CI 1.31 – 8.63), pre-cap PH (IRR 4.11, 95% CI 1.60 – 10.58) and post-cap PH (IRR 5.06, 95% CI 1.63 – 15.67) were associated with increased total HFH. Conclusions: Among patients with MPN who underwent RHC, PH is common and appears to be predominantly isolated pre-capillary and Cpc-PH. Isolated pre- and isolated post-capillary PH were associated with increased HFH. Our study is confounded by selection bias, and therefore prospective studies of PH as diagnosed with RHC are needed in MPNs.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (15)

O

Orly Leiva

University of Chicago, Chicago, Illinois, United States

S

Steven Soo

New York University, New York City, New York, United States

O

Olivia Liu

New York University, New York City, New York, United States

J

Justin Kahla

University of Chicago, Chicago, Illinois, United States

Y

Yasmeen Murtaza

University of Chicago, Chicago, Illinois, United States

V

Victor You

Massachusetts General Hospital, Boston, Massachusetts, United States

A

Andrew Palmer

A

Anand Patel

M

Mark Belkin

UNIVERSITY OF CHICAGO, Chicago, Illinois, United States

S

Stanley Swat

University of Chicago, Chicago, Illinois, United States

L

Leo Gozdecki

University of Chicago, Chicago, Illinois, United States

M

manreet kanwar

University of Chicago, Chicago, Illinois, United States

O

Olatoysoi Odenike

University of Chicago, Chicago, Illinois, United States

J

Joan How

Brigham and Women's Hospital, Boston, Massachusetts, United States

G

Gabriela Hobbs

Massachusetts General Hospital, Boston, Massachusetts, United States